glp-1 weight loss scam The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' New Year, new scam: Fraudsters

In clinical studies, Mounjaro has been shown to produce more significant weight loss than Ozempic

and Kortt N

Understanding which foods to eat while on semaglutide or what to eat on tirzepatide can meaningfully influence how quickly your body responds during this critical building phase

Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work

The Saxenda Spin-Off: Another Weight Management Star While Ozempic and Wegovy have garnered much attention, let's not forget another GLP-1 receptor agonist family member that's been turning heads in the weight management world for years now: Saxenda (liraglutide)